Stay On Top of New Treatments for Alopecia Areata
October 2024
Baricitinib (Olumiant) and ritlecitinib (Litfulo) will be two new once-daily oral treatments for severe alopecia areata.
About 4% of adults and children develop alopecia areata...a condition where the immune system attacks hair follicles and causes patchy or complete hair loss on the scalp, face, or body.
Baricitinib and ritlecitinib work by reducing inflammation, which helps with hair regrowth.
Practical advice for a better career, with unlimited access to CE
Pharmacy Technician's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 120+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote